Join to View Full Profile
15 Parkman StWac 835 Neurology AssociatesBoston, MA 02114
Phone+1 617-726-5532
Fax+1 617-724-1480
Dr. Schwarzschild is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1991 - 1994- Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 1990 - 1991
Harvard Medical SchoolClass of 1990
Certifications & Licensure
MA State Medical License 1994 - 2027
PA State Medical License 2001 - 2009
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2017
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2017
Clinical Trials
- Safety of Urate Elevation in Parkinson's Disease Start of enrollment: 2009 Jun 01
- Study of Urate Elevation in Parkinson's Disease, Phase 3 Start of enrollment: 2016 Jun 01
- Assessing Tele-Health Outcomes in Multiyear Extensions of PD Trials Start of enrollment: 2018 Oct 01
Publications & Presentations
PubMed
- Shotgun Metagenomic Profiling of the Gut Virome in Prodromal and Confirmed Parkinson's Disease.Deepika Dinesh, Xochitl C Morgan, Jordan Jensen, Kjetil Bjornevik, Michael A Schwarzschild
Annals of Neurology. 2026-05-27 - Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.Xiaoying Kang, Zechuan Lin, Fatma Zehra Calikusu, Lauren A Miller, Sofia Soriano
NPJ Parkinson's Disease. 2026-05-14 - Genetic and Proteomic Investigation of the Smoking-Parkinson's Disease Association.Mingjian Shi, Tommy Gunawan, Michael Setzer, Najeah Okashah, Yue Liu
Medrxiv. 2026-04-20
Journal Articles
- Efficacy of Nilotinib in Patients with Moderately Advanced Parkinson DiseaseMichael Schwarzschild, MD, JAMA Neurology
Press Mentions
Antioxidant Fails to Slow Parkinson’s Disease Progression in Clinical TrialSeptember 16th, 2021- Antioxidant Therapy Tested in Early Parkinson’sSeptember 14th, 2021
- NSAIDs Reduce LRRK2 Penetrance in Parkinson's DiseaseSeptember 3rd, 2020
Grant Support
- Planning for Prevention of Parkinson's Disease and Related Synucleinopathies: A trial design forumMASSACHUSETTS GENERAL HOSPITAL2026–2027
- Urate-LRRK2 interactions in Parkinson's diseaseMASSACHUSETTS GENERAL HOSPITAL2019–2025
- Pursuing Purine Pathways To Clinical Trials For Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2009–2012
- Uric Acid:Novel Therapeutic Target For Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2009–2010
- Translational Foundation Of Adenosine Antagonist Use For DyskinesiasNational Institute Of Neurological Disorders And Stroke2006–2010
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
